James J. Burns & Company LLC Acquires Shares of 7,000 Tempus AI, Inc. (NASDAQ:TEM)

James J. Burns & Company LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the fourth quarter, Holdings Channel reports. The firm bought 7,000 shares of the company’s stock, valued at approximately $236,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. First Horizon Advisors Inc. bought a new stake in Tempus AI in the third quarter worth about $30,000. FNY Investment Advisers LLC bought a new stake in shares of Tempus AI in the 4th quarter worth approximately $67,000. Vestor Capital LLC purchased a new position in Tempus AI in the third quarter valued at approximately $153,000. Stifel Financial Corp bought a new position in Tempus AI during the third quarter valued at $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new stake in Tempus AI in the third quarter worth $258,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Loop Capital dropped their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Wolfe Research started coverage on shares of Tempus AI in a research report on Friday, December 13th. They set an “outperform” rating and a $60.00 target price for the company. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price target for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Finally, Needham & Company LLC reissued a “buy” rating and set a $56.00 target price on shares of Tempus AI in a report on Tuesday, January 14th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $56.36.

Insider Activity

In other news, major shareholder Bradley A. Keywell sold 395,800 shares of the stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total value of $16,999,610.00. Following the sale, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. This represents a 2.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Eric P. Lefkofsky sold 476,209 shares of the company’s stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the completion of the transaction, the chief executive officer now owns 6,502,643 shares in the company, valued at approximately $324,091,727.12. The trade was a 6.82 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,037,702 shares of company stock valued at $89,449,651.

Tempus AI Trading Up 7.2 %

NASDAQ:TEM opened at $61.54 on Tuesday. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The firm’s fifty day simple moving average is $44.14 and its 200 day simple moving average is $48.44. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.